基本信息
浏览量:241
职业迁徙
个人简介
By 2011 the VCNDD had grown to approximately 100 full time scientists and under his leadership raised over $100M in external research funding. In addition, the VCNDD advanced novel molecules from multiple major programs into development for major brain disorders with industry partners, including Johnson and Johnson, Astrazeneca, Bristol Myers Squibb, and others. Each of these major efforts are focused on novel mechanisms for therapeutic action that have come from the basic research efforts of Dr. Conn and his collaborators. Dr. Conn has served as Associate Editor and Editor in Chief of Molecular Pharmacology and in editorial positions with multiple other international journals. He has served the Scientific Advisory Boards of multiple foundations, research institutes, and companies. He served as Chairman of the Neuropharmacology Division of the American Society for Pharmacology and Experimental Therapeutics (ASPET), Fellow of the American Association for the Advancement of Science, and on multiple national and international committees. He has received numerous awards, including the NARSAD Essel Distinguished Investigator Award, the ASPET-Astellas Award in Translational Pharmacology, the Pharmacia - ASPET Award for Experimental Therapeutics, the Charles R. Park Award for Basic Research Revealing Insights into Physiology and Pathophysiology, the PhRMA Foundation Award for Excellence in Pharmacology and Toxicology. V. Sagar Sethi Mental Health Research Award, Jacob K. Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders & Stroke. He was named as an ISI Most- Cited Scientists in Pharmacology & Toxicology and the Lee University 2008 Distinguished Alumnus of the Year. Dr. Conn’s current research is focused on development of novel treatment strategies for schizophrenia, Parkinson’s disease, and other serious brain disorders.
研究兴趣
论文共 832 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ACS MEDICINAL CHEMISTRY LETTERSno. 8 (2024): 1358-1366
Julie L. Engers,Katrina A. Bollinger,Rory A. Capstick,Madeline F. Long,Aaron M. Bender,Jonathan W. Dickerson,Weimin Peng, Christopher C. Presley,Hyekyung P. Cho,Alice L. Rodriguez,Colleen M. Niswender,Sean P. Moran, Zixiu Xiang,Anna L. Blobaum,Olivier Boutaud, Jerri M. Rook,Darren W. Engers,P. Jeffrey Conn,Craig W. Lindsley
ASPET 2024 Annual Meeting Abstract - Neuropharmacology (2024)
Jinming Li,Douglas L. Orsi,Julie L. Engers,Madeline F. Long,Rory A. Capstick, Mallory A. Maurer, Christopher C. Presley, Paige N. Vinson,Alice L. Rodriguez, Allie Han,Hyekyung P. Cho,Sichen Chang, Megan Jackson,Michael Bubser,Anna L. Blobaum,Olivier Boutaud,Michael A. Nader,Colleen M. Niswender,P. Jeffrey Conn,Carrie K. Jones,Craig W. Lindsley,Changho Han
JOURNAL OF MEDICINAL CHEMISTRYno. 16 (2024): 14394-14413
NEURONno. 5 (2024): 835-849.e7
Abhishek Shankar Balakrishnan, Laerke Borno Engelhardt Johansen,Craig W. Lindsley,P. Jeffrey Conn,Morgan Thomsen
Julie L Engers, Logan A Baker,Sichen Chang,Vincent B Luscombe, Alice L Rodriguez,Colleen M Niswender,Hyekyung P Cho,Michael Bubser,Analisa Thompson Gray,Carrie K Jones,Weimin Peng, Jerri M Rook,Thomas M Bridges,Olivier Boutaud,P Jeffrey Conn,Darren W Engers,Craig W Lindsley,Kayla J Temple
ACS chemical neuroscience (2024)
Shalini Dogra, Caleb Aguayo,Zixiu Xiang,Jason Putnam,Joshua Smith, Curran Johnston,Daniel J. Foster,Craig W. Lindsley,Colleen M. Niswender,P. Jeffrey Conn
BIOLOGICAL PSYCHIATRYno. 3 (2024): 230-242
Nicole E. Chambers, Annique McLune,Michael Coyle,Ashley Centner,Jordan Sergio, Isabella Delpriore,Kathryn Lanza,Craig W. Lindsley,P. Jeffrey Conn,Christopher Bishop
crossref(2024)
加载更多
作者统计
#Papers: 832
#Citation: 39820
H-Index: 96
G-Index: 175
Sociability: 8
Diversity: 0
Activity: 3
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn